1.34
price up icon0.75%   0.01
after-market Dopo l'orario di chiusura: 1.35 0.01 +0.75%
loading
Precedente Chiudi:
$1.33
Aprire:
$1.34
Volume 24 ore:
2.67M
Relative Volume:
0.81
Capitalizzazione di mercato:
$1.09B
Reddito:
$711.41M
Utile/perdita netta:
$-133.73M
Rapporto P/E:
-7.0526
EPS:
-0.19
Flusso di cassa netto:
$-199.99M
1 W Prestazione:
+5.51%
1M Prestazione:
-2.90%
6M Prestazione:
-7.59%
1 anno Prestazione:
+10.74%
Intervallo 1D:
Value
$1.33
$1.35
Intervallo di 1 settimana:
Value
$1.27
$1.36
Portata 52W:
Value
$1.19
$2.035

Opko Health Inc Stock (OPK) Company Profile

Name
Nome
Opko Health Inc
Name
Telefono
305-575-4181
Name
Indirizzo
4400 BISCAYNE BLVD., MIAMI, FL
Name
Dipendente
2,997
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
OPK's Discussions on Twitter

Confronta OPK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
OPK
Opko Health Inc
1.34 1.09B 711.41M -133.73M -199.99M -0.19
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
427.76 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
202.50 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
542.71 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
120.66 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
164.65 27.64B 15.50B 1.33B 2.16B 7.34

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-25 Iniziato JP Morgan Neutral
2023-06-29 Aggiornamento Barrington Research Mkt Perform → Outperform
2022-12-15 Iniziato H.C. Wainwright Buy
2022-01-24 Downgrade Barrington Research Outperform → Mkt Perform
2021-06-21 Iniziato Ladenburg Thalmann Buy
2019-11-25 Iniziato Piper Jaffray Overweight
2018-03-02 Downgrade JP Morgan Neutral → Underweight
2017-09-14 Downgrade JP Morgan Overweight → Neutral
2016-06-21 Reiterato Standpoint Research Buy
2016-06-03 Iniziato Standpoint Research Buy
2016-03-31 Reiterato Barrington Research Outperform
2015-10-16 Iniziato JP Morgan Overweight
2015-09-11 Downgrade Jefferies Buy → Hold
2015-03-03 Downgrade Oppenheimer Outperform → Perform
2014-05-12 Reiterato Oppenheimer Outperform
2014-03-14 Iniziato Oppenheimer Outperform
2013-11-13 Reiterato Ladenburg Thalmann Buy
2013-05-30 Reiterato Ladenburg Thalmann Buy
2012-10-22 Iniziato Barrington Research Outperform
2011-12-01 Reiterato Ladenburg Thalmann Buy
2011-07-14 Iniziato Ladenburg Thalmann Buy
Mostra tutto

Opko Health Inc Borsa (OPK) Ultime notizie

pulisher
Jun 18, 2025

Shareholders in OPKO Health (NASDAQ:OPK) have lost 51%, as stock drops 6.5% this past week - simplywall.st

Jun 18, 2025
pulisher
Jun 14, 2025

Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Quote - OPKO Health, Inc.

Jun 13, 2025
pulisher
Jun 13, 2025

Bone Cancer Drugs Market Set to Witness Significant Growth - openPR.com

Jun 13, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Has $855,000 Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jun 13, 2025
pulisher
Jun 11, 2025

OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy (NASDAQ:OPK) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 09, 2025

ModeX assembles advisory board for antibody development By Investing.com - Investing.com India

Jun 09, 2025
pulisher
Jun 09, 2025

ModeX assembles advisory board for antibody development - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health's ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development - The Manila Times

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health's (OPK) ModeX Therapeutics Forms Scientific Advisory Board - StreetInsider

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development - GlobeNewswire Inc.

Jun 09, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Boosts Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Cuts Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jun 05, 2025
pulisher
Jun 04, 2025

OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Two Sigma Investments LP - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Peptide Therapeutics Market Growth Set to Surge Significantly - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

Bone Cancer Drugs Market in 2025-2032 Detailed Study Analysis - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Sells 195,118 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 8,064 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Q2 EPS Estimates for OPKO Health Reduced by Zacks Research - MarketBeat

May 31, 2025
pulisher
May 31, 2025

Millennium Management LLC Boosts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

Deutsche Bank AG Grows Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 30, 2025
pulisher
May 29, 2025

Opko Health grants stock options, approves bonuses - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Opko Health grants stock options, approves bonuses By Investing.com - Investing.com Nigeria

May 29, 2025
pulisher
May 29, 2025

Opko Health Grants Stock Options and Bonuses - TipRanks

May 29, 2025
pulisher
May 28, 2025

OPKO Health (OPK) Rises with Promising Oncology Developments - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SA Asks: What are the best oncology stocks right now? - Seeking Alpha

May 28, 2025
pulisher
May 27, 2025

Millennium Management LLC Boosts Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 27, 2025
pulisher
May 26, 2025

Down Syndrome Market: Epidemiology, Therapies, Companies, - openPR.com

May 26, 2025
pulisher
May 24, 2025

What OPKO Health, Inc.'s (NASDAQ:OPK) P/S Is Not Telling You - simplywall.st

May 24, 2025
pulisher
May 22, 2025

Hyperparathyroidism Treatment Market: Effective Treatment - openPR.com

May 22, 2025
pulisher
May 22, 2025

OPKO Health, Inc. (NASDAQ:OPK) Shares Acquired by Lazard Asset Management LLC - MarketBeat

May 22, 2025
pulisher
May 20, 2025

Opko Health at BioConnect: Strategic Shifts and Financial Insights By Investing.com - Investing.com India

May 20, 2025
pulisher
May 18, 2025

Opko Completes Prolor Deal - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Mercer Global Advisors Inc. ADV Grows Stake in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 18, 2025
pulisher
May 17, 2025

Strong week for OPKO Health (NASDAQ:OPK) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance

May 17, 2025
pulisher
May 15, 2025

Esoteric Testing Market Set to Witness Significant Growth - openPR.com

May 15, 2025
pulisher
May 15, 2025

OPKO Health to Participate in Two Upcoming Investor Conferences - GlobeNewswire

May 15, 2025
pulisher
May 14, 2025

Dimensional Fund Advisors LP Lowers Position in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 14, 2025

Opko Health Inc Azioni (OPK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Opko Health Inc Azioni (OPK) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 08 '25
Buy
1.48
125,000
184,650
213,876,448
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 01 '25
Buy
1.65
100,000
164,850
213,751,448
FROST PHILLIP MD ET AL
CEO & Chairman
Mar 28 '25
Buy
1.70
150,000
254,385
213,651,448
FROST PHILLIP MD ET AL
CEO & Chairman
Mar 17 '25
Buy
1.74
200,000
347,820
213,501,448
FROST PHILLIP MD ET AL
CEO & Chairman
Feb 28 '25
Buy
1.71
67,434
115,312
213,301,448
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 28 '25
Buy
1.47
47,537
70,060
213,234,014
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 17 '25
Buy
1.47
150,000
220,425
213,186,477
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 15 '25
Buy
1.48
500,000
740,850
213,036,477
FROST PHILLIP MD ET AL
CEO & Chairman
Dec 13 '24
Buy
1.59
125,000
199,375
212,536,477
FROST PHILLIP MD ET AL
CEO & Chairman
Dec 11 '24
Buy
1.56
500,000
781,050
212,411,477
diagnostics_research DGX
$176.60
price down icon 1.52%
diagnostics_research WAT
$351.92
price down icon 1.43%
diagnostics_research LH
$260.00
price down icon 1.61%
$161.57
price up icon 0.53%
diagnostics_research MTD
$1,205.65
price up icon 0.03%
diagnostics_research IQV
$164.65
price up icon 1.25%
Capitalizzazione:     |  Volume (24 ore):